Dyne Therapeutics DYN
NASDAQ DYN
$15.82 -0.29 (-1.80%)
At close: Oct 1, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Dyne Therapeutics (DYN) posted Depreciation & Amortization (CF) of $600,000 for Q2 2026, up 20.0% from $500,000 a year earlier and unchanged from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Dyne Therapeutics was $2.22 million, up 18.2% year-over-year; for FY2025, it came in at $2.05 million, up 20.5% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
  • In prior years, Dyne Therapeutics' Depreciation & Amortization (CF) was $1.7 million in FY2024 (unchanged), $1.7 million in FY2023 (+1.0%), $1.68 million in FY2022 (+53.0%) and $1.1 million in FY2021 (+57.1%).
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last seven quarters, with growth averaging 17.9% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2022, with growth of 150.0%; the weakest was Q2 2023, with a decline of 20.0%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $600,000 (Q1 2026), $521,000 (Q4 2025) and $500,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Dyne Therapeutics 2.67 Bn 2.67 Bn - 600,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600,000.00
Mar 31, 2026 600,000.00
Dec 31, 2025 521,000.00
Sep 30, 2025 500,000.00
Jun 30, 2025 500,000.00
Mar 31, 2025 502,000.00
Dec 31, 2024 477,000.00
Sep 30, 2024 400,000.00
Jun 30, 2024 400,000.00
Mar 31, 2024 400,000.00
Dec 31, 2023 400,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 400,000.00
Mar 31, 2023 412,000.00
Dec 31, 2022 383,000.00
Sep 30, 2022 400,000.00
Jun 30, 2022 500,000.00
Mar 31, 2022 425,000.00
Dec 31, 2021 353,000.00
Sep 30, 2021 300,000.00
API Access

Dyne Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=DYN&period=max&api_key=YOUR_API_KEY